|
A
number of Nycomed Amersham's diagnostic and therapeutic products owe
their effectiveness to the use of small amounts of radioactivity,
as do some of Amersham Pharmacia Biotech's life science technologies.
A wide range of isotopes is used in various products in quantities
dependent upon the application. Some of the commonly used isotopes
for diagnosis include those of iodine, technetium and thallium; therapeutic
isotopes include those of iodine and strontium; life science uses
include tritium, carbon 14 and phosphorous 32.
All sites using radionuclides in research or
manufacture are strictly regulated by external authorities. These
controls embrace the transport, packaging, handling, storage and
use of radioisotopes and the management of residues from the production
process. All the company's nuclear licensed sites comply fully with
the strictly set legal limits for safe discharges and waste storage.
The company has also been investing in
new technologies and techniques to improve its radioactive waste
management procedures. These include reducing wherever possible
the amount generated and storing or disposing of residues to the
highest standards. In the UK, this led the company to invest in
its own state-of-the-art facility for storage of intermediate level
waste until a Government approved facility is constructed.
|